136 USABILITY AND INCIDENCE OF DETRUSOR OVERACTIVITY PATTERNS IN ONE YEAR OF URODYNAMIC STUDIES

136 USABILITY AND INCIDENCE OF DETRUSOR OVERACTIVITY PATTERNS IN ONE YEAR OF URODYNAMIC STUDIES

Bibliographic Details
Main Authors:	T Van Steenbergen, P Rosier
Format:	Article
Language:	English
Published:	Elsevier 2022-06-01
Series:	Continence
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772973722005379

Similar Items

Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
by: Mohammed A. Al-Ghazo, et al.
Published: (2011-03-01)

OBJECTIVE PARAMETERS TO DESCRIBE DETRUSOR OVERACTIVITY PATTERS
by: T van Steenbergen, et al.
Published: (2023-09-01)

Differences in the Urinary Microbiome of Patients with Overactive Bladder Syndrome with and without Detrusor Overactivity on Urodynamic Measurements
by: Aida Javan Balegh Marand, et al.
Published: (2023-05-01)

Patient treatment preferences for symptomatic refractory urodynamic idiopathic detrusor overactivity
by: Christina L Fontaine, et al.
Published: (2017-01-01)

Phasic or terminal detrusor overactivity in women: age, urodynamic findings and sphincter behavior relationships
by: Françoise A. Valentini, et al.
Published: (2011-12-01)

83 - Does detrusor overactivity cause detrusor underactivity through muscle exhaustion? Results from a urodynamic database
by: Eleonora Rosato, et al.
Published: (2023-06-01)

QUANTITATIVE SPECTRAL ANALYSIS OF URODYNAMICS IDENTIFIES BOTH DETRUSOR OVERACTIVITY AND SEVERE URGENCY SYMPTOMS
by: D Ward Grados, et al.
Published: (2023-09-01)

Investigating Urine Biomarkers in Detrusor Underactivity and Detrusor Overactivity with Detrusor Underactivity Patients
by: Yuan-Hong Jiang, et al.
Published: (2023-04-01)

Re: The Clinical and Urodynamic Results of Percutaneous Posterior Tibial Nerve Stimulation on Neurogenic Detrusor Overactivity in Patients with Parkinson’s Disease
by: Lokman İrkilata
Published: (2015-12-01)

Efficacy and safety of propiverine and terazosine combination for one year in male patients with luts and detrusor overactivity
by: Nevzat Can Sener, et al.
Published: (2013-07-01)

Efficacy, according to urodynamics, of OnabotulinumtoxinA compared with antimuscarinic drugs, for neurogenic detrusor overactivity: a systematic review and network meta-analysis
by: Rui Xu, et al.
Published: (2022-10-01)

Clinical and urodynamic effects of tolterodine in women with an overactive bladder
by: Chiu-Lin Wang, et al.
Published: (2013-09-01)

Increased detrusor collagen is associated with detrusor overactivity and decreased bladder compliance in men with benign prostatic obstruction
by: Carlos H.S. Bellucci, et al.
Published: (2017-06-01)

Urinary ATP may be a dynamic biomarker of detrusor overactivity in women with overactive bladder syndrome.
by: Miguel Silva-Ramos, et al.
Published: (2013-01-01)

Role of percutaneous tibial nerve stimulation in the management of the detrusor overactivity
by: Emad K El Tair, et al.
Published: (2022-01-01)

Coexistent Detrusor Overactivity-Underactivity in Patients with Pelvic Floor Disorders
by: Matteo Frigerio, et al.
Published: (2022-09-01)

Efficacy of botulinum toxin in a patient with neurogenic detrusor overactivity
by: S. S. Nikitin, et al.
Published: (2022-09-01)

The Botulinum Treatment of Neurogenic Detrusor Overactivity: The Double-Face of the Neurotoxin
by: Chiara Traini, et al.
Published: (2019-10-01)

Patient characteristics, symptoms, and urodynamic parameters associated with detrusor contraction duration in women
by: Connie N. Wang, et al.
Published: (2023-05-01)

Efficacy and Safety of Low-Dose Intravesical OnabotulinumtoxinA Injections in Female Patients With Detrusor Overactivity With Detrusor Underactivity
by: Hyun Seok Na, et al.
Published: (2024-03-01)

Effect of botulinum toxin type A on idiopathic and neurogenic detrusor overactivity
by: Jurij Leskovar, et al.
Published: (2010-06-01)

Botulinum toxin A for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients
by: S. Deffontaines-Rufin, et al.
Published: (2011-10-01)

Urodynamic outcome of parasacral transcutaneous electrical neural stimulation for overactive bladder in children
by: Ubirajara Barroso Jr., et al.
Published: (2015-08-01)

De Novo Detrusor Underactivity and Other Urodynamic Findings after Radical Prostatectomy: A Systematic Review
by: Maciej Oszczudłowski, et al.
Published: (2022-03-01)

Short-term outcome of onabotulinumtoxin A injection for the treatment of refractory idiopathic detrusor overactivity
by: Gamal E A. Abourjila, et al.
Published: (2020-01-01)

EP3 ANTAGNOIST ALLEVIATE DETRUSOR OVERACTIVITY IN COMPLETE SPINAL CORD INJURY RATS
by: L Lv, et al.
Published: (2023-09-01)

Oxybutynin and tolterodine for treatment of neurogenic detrusor overactivity: a pharmacoeconomic evaluation in the Brazilian context
by: Rodrigo Silva Suguino, et al.
Published: (2012-06-01)

OPPORTUNITY FOR ICS URODYNAMIC STANDARDIZATION: SENSATION, RECTAL ACTIVITY, AND UNINHIBITED DETRUSOR CONTRACTIONS – A SURVEY OF ICS MEMBERS
by: B Roberts, et al.
Published: (2023-09-01)

EFFECT OF BLADDER OUTLET PROCEDURES ON URODYNAMIC ASSESSMENTS IN MEN WITH AN ACONTRACTILE OR UNDERACTIVE DETRUSOR: A SYSTEMATIC REVIEW AND META-ANALYSIS
by: N Merode van, et al.
Published: (2023-09-01)

74 - Invasive urodynamics in patients with refractory overactive bladder: A modified Delphi consensus
by: Cosimo De Nunzio, et al.
Published: (2023-06-01)

Urinary Oxidative Stress Biomarkers in the Diagnosis of Detrusor Overactivity in Female Patients with Stress Urinary Incontinence
by: Wei-Hsin Chen, et al.
Published: (2023-01-01)

Intravesical electromotive botulinum toxin-A administration: Will it be the standard treatment for refractory neurogenic detrusor overactivity?
by: Neeraj Kumar Goyal, et al.
Published: (2011-01-01)

BoNT/A1 Secondary Failure for the Treatment of Neurogenic Detrusor Overactivity: An Ex Vivo Functional Study
by: Jacquie Maignel, et al.
Published: (2022-01-01)

Long-term follow-up of intravesical abobotulinumtoxinA (Dysport®) injections in women with idiopathic detrusor overactivity
by: Mohammad Sajjad Rahnama'i, et al.
Published: (2024-01-01)

Editorial Comment: Solifenacin treatment after intradetrusor injections with botulinum toxin in patients with neurogenic detrusor overactivity
by: Marcio Augusto Averbeck
Published: (2022-11-01)

Percutaneous tibial nerve stimulation in the treatment of neurogenic detrusor overactivity in multiple sclerosis patients: a historically controlled study
by: Marco Carilli, et al.
Published: (2023-05-01)

Effectiveness and Safety of Intradetrusor OnabotulinumtoxinA Injection for Neurogenic Detrusor Overactivity and Overactive Bladder Patients in Taiwan—A Phase IV Prospective, Interventional, Multiple-Center Study (Restore Study)
by: Chung-Cheng Wang, et al.
Published: (2021-12-01)

Long-term response of different Botulinum toxins in refractory neurogenic detrusor overactivity due to spinal cord injury
by: Giuseppe Lombardi, et al.

135 TEST-RETEST VARIATION OF DETRUSOR VOIDING CONTRACTION WITH VARIATION OF BLADDER OUTFLOW RESISTANCE IN MEN WITH LUTS.
by: C Donkelaar, et al.
Published: (2022-06-01)

Bladder contractility index changes with short-term antimuscarinic therapy in patients with detrusor overactivity: A placebo controlled randomised study
by: Alka Ashok Bhide, et al.
Published: (2023-12-01)